Mattia Giovannini

ORCID: 0000-0001-9568-6882
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Eosinophilic Esophagitis
  • Drug-Induced Adverse Reactions
  • Contact Dermatitis and Allergies
  • Urticaria and Related Conditions
  • Respiratory and Cough-Related Research
  • Dermatology and Skin Diseases
  • Mast cells and histamine
  • Pharmaceutical studies and practices
  • Autoimmune Bullous Skin Diseases
  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Inhalation and Respiratory Drug Delivery
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Infections and Vaccines
  • Eosinophilic Disorders and Syndromes
  • Immunodeficiency and Autoimmune Disorders
  • Vaccine Coverage and Hesitancy
  • Celiac Disease Research and Management
  • Occupational exposure and asthma
  • Cardiac Arrhythmias and Treatments
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Influenza Virus Research Studies

Meyer Children's Hospital
2016-2025

University of Florence
2016-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2023-2025

Meyer Children's Hospital
2020-2024

ENT and Allergy
2023

Meyer (China)
2023

King's College London
2020-2022

Temple Street Children's University Hospital
2020-2021

Weatherford College
2021

Sapienza University of Rome
2021

Stephanie Dramburg Christiane Hilger Alexandra F. Santos Leticia de las Vecillas Rob C. Aalberse and 95 more Nathalie Acevedo Lorenz Aglas Friedrich Altmann L. Karla Arruda Riccardo Asero Barbara Ballmer‐Weber Domingo Barber Kirsten Beyer Tilo Biedermann Maria Beatrice Bilò Simon Blank Philipp P. Bosshard Heimo Breiteneder Helen A. Brough Merima Bublin Dianne E. Campbell Luis Caraballo Jean‐Christoph Caubet Giorgio Celi Martin D. Chapman M. Chruszcz Adnan Ćustović Rebecca Czolk Janet M. Davies Nikolaos Douladiris Bernadette Eberlein Motohiro Ebisawa Anna M. Ehlers Philippe Eigenmann Gabriele Gadermaier Mattia Giovannini Francisca Gómez Rebecca Grohman Carole Guillet Christine Häfner Robert G. Hamilton Michael Hauser Thomas Hawranek Hans Jürgen Hoffmann Thomas Holzhauser Tomona Iizuka Alain Jacquet Thilo Jakob Bente Janssen‐Weets Uta Jappe Marek Jutel Tanja Kalic Sandip D. Kamath S. Kespohl Jörg Kleine‐Tebbe Edward F. Knol André C. Knulst Jon R. Konradsen Peter Korošec Annette Kuehn Gideon Lack Thuy‐My Le Andreas L. Lopata Olga Luengo Mika J. Mäkelä Alessandro Maria Marra E. N. Clare Mills M. Morisset Antonella Muraro Anna Nowak‐Węgrzyn Roni Nugraha Markus Ollert Kati Palosuo Elide A. Pastorello Sarita U. Patil Thomas A.E. Platts‐Mills Anna Pomés Pascal Poncet Ekaterina Potapova Lars K. Poulsen Christian Radauer Suzana Radulovič Monika Raulf Pierre Rougé J. Sastre Sakura Sato Enrico Scala Johannes Martin Schmid Peter Schmid‐Grendelmeier Denise Schrama Hélène Sénéchal Claudia Traidl‐Hoffmann Marcela Valverde‐Monge Marianne van Hage Ronald van Ree Kitty Verhoeckx Stefan Vieths Magnus Wickman Josefina Zakzuk Paolo Maria Matricardi

Abstract Since the discovery of immunoglobulin E (IgE) as a mediator allergic diseases in 1967, our knowledge about immunological mechanisms IgE‐mediated allergies has remarkably increased. In addition to understanding immune response and clinical symptoms, allergy diagnosis management depend strongly on precise identification elicitors reaction. past four decades, innovations bioscience technology have facilitated production well‐defined, highly pure molecules for component‐resolved (CRD),...

10.1111/pai.13854 article EN cc-by-nc Pediatric Allergy and Immunology 2023-03-01

Abstract This European Academy of Allergy and Clinical Immunology guideline provides recommendations for diagnosing IgE‐mediated food allergy was developed using the Grading Recommendations, Assessment, Development Evaluations (GRADE) approach. Food diagnosis starts with an allergy‐focused clinical history followed by tests to determine IgE sensitization, such as serum allergen‐specific (sIgE) skin prick test (SPT), basophil activation (BAT), if available. Evidence sensitization should be...

10.1111/all.15902 article EN cc-by-nc Allergy 2023-10-10

Abstract Background IgE‐mediated food allergy (FA) is a global health concern with substantial individual and societal implications. While diverse intervention strategies have been researched, inconsistencies in reported outcomes limit evaluations of FA treatments. To streamline promote consistent reporting, the Core Outcome Measures for Food Allergy (COMFA) initiative aimed to establish Set (COS) clinical trials observational studies interventions. Methods The project involved review...

10.1111/all.16023 article EN cc-by-nc Allergy 2024-03-03

This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management IgE-mediated food allergy was developed using Grading Recommendations, Assessment, Development Evaluations (GRADE) approach. Following confirmation diagnosis, allergen avoidance dietary advice (with support a specialised dietitian, if possible) together with provision written treatment plan, education on recognition allergic symptoms prescription medication including...

10.1111/all.16345 article EN cc-by Allergy 2024-10-30

A few years after the introduction in Italy of a four-component anti-meningococcal B vaccine (4CMenB), we evaluated effectiveness and impact vaccination two regions using different schedules (2, 4, 6, 12 months Tuscany vs. 7, 9, 15 Veneto) through an observational retrospective study.Vaccination started 2014 2015 Veneto; data collected referred to period 2006-2018 for 2007-2018 Veneto. Cases invasive meningococcal disease due N. Meningitidis were identified by culture and/or real-time PCR.In...

10.3390/vaccines8030469 article EN cc-by Vaccines 2020-08-22

Abstract Background In allergic rhinitis and asthma, adolescents young adult patients are likely to differ from older patients. We compared adolescents, adults on symptoms, control levels, medication adherence. Methods a cross‐sectional study (2015–2022), we assessed European users of the MASK‐air mHealth app three age groups: (13–18 years), (18–26 (>26 years). them their reported asthma use adherence treatment Allergy symptoms were by means visual analogue scales (VASs) or combined...

10.1111/pai.14080 article EN cc-by-nc Pediatric Allergy and Immunology 2024-02-01

Respiratory Syncytial Virus (RSV) is associated with most of the acute viral respiratory tract infections causing hospitalization a peak during first months life. Many clinical trials RSV vaccine candidates are being carried out. The aim this study was to obtain epidemiologic information give suggestions on target populations and prevention strategies before introduction new vaccines or monoclonal antibodies. We retrospectively evaluated, over 5-year period (September 2014-August 2019),...

10.3390/vaccines8010015 article EN cc-by Vaccines 2020-01-04

As in many fields of medical care, the coronavirus disease 2019 (COVID-19) resulted an increased uncertainty regarding safety allergen immunotherapy (AIT). Therefore, European Academy Allergy and Clinical Immunology (EAACI) aimed to analyze situation different countries systematically collect all information available tolerability possible amendments daily practice sublingual AIT (SLIT), subcutaneous (SCIT) for inhalant allergies venom AIT.Under framework EAACI, a panel experts field...

10.1111/all.14793 article EN cc-by-nc Allergy 2021-03-03
Coming Soon ...